Clinical trials
Completed Phase 1 Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Geisinger Clinic | 1 |
| Genzyme, a Sanofi Company | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Center for Research Resources (NCRR) | 1 |
| University of Tehran | 1 |
| Verve Therapeutics, Inc. | 1 |
| Visirna Therapeutics HK Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 10 |
| Hypertriglyceridemia | 3 |
| Dyslipidemias | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 |
| Hereditary Breast and Ovarian Cancer Syndrome | 1 |
| Hypercholesterolemia | 1 |
| Metabolism, Inborn Errors | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.